Newly Launched Replay Has Big Plans For Writing and Delivering ‘Big DNA’

Viral Vector Has 30 Times Capacity Of AAV

 
• By Andrew McConaghie
Herpes Simplex
One of the company's key technologies is a herpes simplex virus based gene therapy. • Source: Shutterstock

More from Business

More from Scrip